Clinical Trial Update: Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of pioglitazone and exenatide on body weight and beta cell function in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes, Healthy | Phase 4 | Status: COMPLETED | Results posted: 2015-03-17